ROSES-S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS-CoV-2.

World Health Organization Seroepidemiology Technical Working Gro; (2021) ROSES-S: Statement from the World Health Organization on the reporting of seroepidemiologic studies for SARS-CoV-2. Influenza and Other Respiratory Viruses, 15 (5). pp. 561-568. ISSN 1750-2640 DOI: 10.1111/irv.12870
Copy

Well-designed population-based seroepidemiologic studies can be used to refine estimates of infection severity and transmission, and are therefore an important component of epidemic surveillance. However, the interpretation of the results of seroepidemiologic studies for SARS-CoV-2 has been hampered to date principally by heterogeneity in the quality of the reporting of the results of the study and a lack of standardized methods and reporting. We provide here the ROSES-S: Reporting of Seroepidemiologic studies-SARS-CoV-2. This is an updated checklist of 22 items that should be included in the reporting of all SARS-CoV-2 seroepidemiologic studies, irrespective of study design.



picture_as_pdf
WHO_2021_ROSES-s-statement-from-the.pdf
subject
Published Version
Available under Creative Commons: 4.0

View Download

Explore Further

Find work associated with the faculties and division(s):

Find work associated with the research centre(s):

Find work from this publication: